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rized from 1 to 3 in “no”, “quite” and “a lot of expectations”.
The ANOVA test was used to evaluate the impact of the expec-
tations on the measured outcomes. RESULTS: There were 884
patients (360 hips and 524 knees) who replied the two times. In
all the physic-functional expectations items patients showed sta-
tistically signiﬁcant improvements in all HRQOL dimensions
except in the Mental Component Summary (MCS) of the SF-12,
observing an ascending gradient, so the higher the prior-surgery
expectations are, the greater the improvement is, at 12 months
post-surgery. Regarding the two questions about social expecta-
tions, in both of them the results were equal to the physic-
functional expectations in all dimensions. The question about
psychological expectations keeps on showing this signiﬁcant
improvement in all the dimensions with the same ascending
gradient CONCLUSIONS: Patient expectations prior-surgery
were important predictors of improvement outcomes in health
related quality of life at 12 months after THR and TKR.
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OBJECTIVES: In a study aimed at measuring the effectiveness of
Adalimumab in HRQL of moderate to severe RA patients as
prescribed by rheumatologists in normal clinical setting in Greece
we examined the HRQL levels and the correlation among HRQL
measures in RA patients. METHODS: An open label, 52-week
follow-up study of 120 patients is being conducted in ten hospi-
tals. In total, 36 RA patients are so far enrolled and 21 CRFs
have been collected. Two generic instruments—the EQ-5D Ques-
tionnaire and the Medical Outcome Study (MOS) Short-Form 36
(SF-36)- and one disease-speciﬁc–the Health Assessment Ques-
tionnaire (HAQ)—were implemented. Correlation analysis was
used to identify the relationship among HRQL measures, and
reliability analysis to test internal consistency. RESULTS: RA
patients’ mean age was 58.5 years (Std.D. 10.8), while 81% were
women. The mean values of the SF-36 scales were: VT 35.2
(Std.D. 33.3), SF 48.2 (Std.D. 38.8), RE 34.9 (Std.D. 47.6), MH
48.7 (Std.D. 21.6), PF 34.5 (Std.D. 22.6), RP 11.9 (Std.D. 28),
BP 33.5 (Std.D. 18.6), GH 38.5 (Std.D. 19.7). 81% of RA
patients had moderate mobility problems and 61.9% with self-
care. Moderate problems in doing usual activities had 81%,
while 42.9% complained about pain/discomfort. 14.3% of RA
patients were extremely anxious/depressed. The mean VAS value
was 28.6 (Std.D. 27.5), while mean HAQ score 1.2 (Std.D. 1.3).
A statistically signiﬁcant correlation was found between HAQ
and all the SF-36 scales. Correlation coefﬁcients ranged from
-0.471 (GH) to -0.786 (PF) at level 0.01. HAQ was strongly
correlated with the mobility (r = 0.531), self-care (r = 0,546),
and usual activity (r = 0,513) of the EQ-5D at level 0.05. Cron-
bach’ alpha coefﬁcients for HAQ, SF-36 and EQ-5D were 0.856,
0.879 and 0.552 respectively. CONCLUSIONS: RA patients
recorded signiﬁcantly low levels of HRQL. The study reveals a
statistically signiﬁcant correlation among HAQ, SF-36 and
EQ-5D.
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OBJECTIVES: To describe the clinical fracture outcomes, health
related QoL and back pain (BP) in postmenopausal women with
osteoporosis treated with teriparatide (Forsteo®) in France.
METHODS: European, prospective, observational study of 36
month duration (18 months: active treatment phase and 18
months: post-treatment follow up) in postmenopausal patients
with osteoporosis that received a prescription of teriparatide.
Clinical fragility fractures, QoL measured by EQ-5D and BP by
a Visual Analogue Scale (VAS) and a questionnaire were col-
lected. RESULTS: Among 309 patients enrolled in France, 223
(72.2%) patients completed the 18 month visit. Follow-up data
were available for 292 (94.5%) patients. At baseline, mean (SD)
age was 74.5 (7.4) years, 96.8% of patients had 2 or more
prevalent fractures occurred after age 40, the mean number of
fractures (SD) was 4.2 (1.7) and median number was 4.0 (inter-
quartile range 3.0–5.0). During the study, 43 women (14.7%)
sustained a total of 48 incident fractures (50.0% clinical verte-
bral, 50.0% non-vertebral). Between baseline and 18 months
visit, EQ-5D Health State Values improved in 63.2% of patients
and median (Q1;Q3) values increased from 0.52 (0.03;0.69) to
0.69 (0.52;0.76). Back pain improved between baseline and 18
months visit: Percentage of patients suffering from back pain
everyday or almost everyday decreased from 76.6% to 31.4%,
moderate or severe back pain from 93.1% to 66.5%, severe
activities limitations from 46.9% to 12.6%. Mean back pain
intensity (VAS [SD]) decreased from 56.2 (24.9) mm to 34.1
(22.5) mm and was improved in 70.3% of patients who had a
baseline intensity over 67 mm. CONCLUSIONS: French patients
with osteoporosis were treated with teriparatide. These patients
had severe osteoporosis associated with back pain which
impacted on daily activities Improved quality of life and back
pain were observed during teriparatide treatment and 14.7% of
patients had a new fracture.
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OBJECTIVES: To maintain good quality of life (QOL) is an
important goal in the management of patients with rheumatoid
arthritis (RA). Since QOL of RA patients is inﬂuenced by many
factors, we quantitatively measured QOL of RA patients based
on Japanese version of EuroQoL (EQ-5D), and we analyzed the
major determinants of EQ-5D in RA patients using a large obser-
vational cohort of RA patients in Japan. METHODS: IORRA
(Institute Of Rheumatology Rheumatoid Arthritis) is an obser-
vational cohort of RA patients established in the Institute of
Rheumatology Tokyo Women’s Medical University since 2000.
Essentially all RA patients who consulted there were registered,
and clinical parameters including the disease activity, use of drugs
and the occurrence of adverse events in daily clinical settings
were assessed biannually based on patient’s report, physician’s
A552 Abstracts
